PHESGO® is a subcutaneous combination of pertuzumab and trastuzumab for HER2-positive breast cancer, designed to reduce treatment time.
Related products
Xeloda 500mg x 120Caps (NAFDAC)
Capecitabine
Wegovy 2.4mg/0.7ml Inj. x 1Pen
Semaglutide Injection
Wegovy 7.2mg/0.75ml Prefilled Inj. x 4 Pens (UK)
Zoladex 10.8mg Inj. x 1 (NAFDAC)
Wegovy 1.7mg/0.7ml Inj. x 1Pen
Semaglutide Injection
















